Inventor · disambiguated record
Wenshan Hao
Also filed as: HAO WENSHAN
3 granted patents·4 pending applications·0 citations·filing 2016–2025
48Inventor score
Files withNEOMICS PHARMACEUTICALS LLC3JN THERAPEUTICS2Neomics Pharmaceutials LLC1SHANGHAI FUDAN ZHANGJIANG BIO PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
7 records- 0161US12024511B2Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereofSHANGHAI FUDAN ZHANGJIANG BIO PHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 2, 2024·0 cites·20 claims
- 0260US12263221B2Chimeric antigen receptor comprising BCMA nanobody linked to a chimeric intracellular signaling domainNEOMICS PHARMACEUTICALS LLC·Filed 2023·Granted Apr 1, 2025·0 cites·7 claims
- 0357US10730875B2Substituted imidazo[1,2-A]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereofJN THERAPEUTICS·Filed 2019·Granted Aug 4, 2020·0 cites·22 claims
- 0445US2025195657A1Chimeric antigen receptor comprising bcma nanobody linked to a chimeric intracellular signaling domainNEOMICS PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 0541US2025352581A1Combination therapies comprising functional components of pd-1 switch receptor and fas dominant negative receptorNeomics Pharmaceutials LLC·Filed 2025·Application pending·0 cites
- 0641US2018002328A1Substituted imidazo[1, 2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereofJN THERAPEUTICS·Filed 2016·Application pending·0 cites
- 0741US2022220186A1Chimeric co-stimulatory proteins comprising mutant intracellular domains with increased expressionNEOMICS PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wenshan Hao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →